entity

Glucosylceramide

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Glucosylceramide: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2Connections
0Hypotheses
1Analyses
1Outgoing
1Incoming
0Experiments

Wiki Pages (20)

Knowledge base pages for this entity

Parkinson's Disease

disease · 8807 words

Atypical Parkinsonism

disease · 6876 words

Mitophagy Pathway in Neurodegeneration

mechanism · 4637 words

Synaptic Vesicle Trafficking in Parkinson's Disease

mechanism · 4417 words

GBA Pathway in Parkinson's Disease

mechanism · 4381 words

Outgoing (1)

TargetRelationTypeStr
Gaucher diseasecontributes_todisease0.95

Incoming (1)

SourceRelationTypeStr
glucocerebrosidaseregulatesprotein0.70

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

What is the therapeutic window between GCS inhibition efficacy and systemic toxi

neurodegeneration | 2026-04-11 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found